Malignancy in Crohn's disease: Incidence and clinical characteristics in Japan

Digestion

Volumn 81, Issue 4, 2010, Pages 265-270

  Mizushima, Tsunekazu ^a   Ohno, Yuko ^a   Nakajima, Kiyokazu ^a   Kai, Yasuyuki ^a   Iijima, Hideki ^a   Sekimoto, Mitsugu ^a   Nishida, Toshirou ^a   Nezu, Riichiro ^b   Ito, Toshinori ^a   Doki, Yuichiro ^a   Mori, Masaki ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA ROSAI HOSPITAL   (Japan)

Author keywords

Colorectal cancer; Crohn's disease; Japanese

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BILE DUCT CANCER; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER OF UNKNOWN PRIMARY SITE; CANCER RISK; CHILD; CROHN DISEASE; FEMALE; HUMAN; INTESTINE CANCER; JAPAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; STOMACH CANCER; UTERUS CANCER;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; COLORECTAL NEOPLASMS; CONFIDENCE INTERVALS; CROHN DISEASE; DATABASES, FACTUAL; ENDOMETRIAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; JAPAN; MALE; MIDDLE AGED; NEOPLASMS; PRECANCEROUS CONDITIONS; PROBABILITY; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEX DISTRIBUTION; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 75649086037     PISSN: 00122823     EISSN: None     Source Type: Journal    
DOI: 10.1159/000273784     Document Type: Article

References (43)

1. Eaden JA, Abrams KR, Mayberry JF: The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 2001; 48: 526-535. (Pubitemid 32234798)
2. Weedon DD, Shorter RG, Ilstrup DM, Huizenga KA, Taylor WF: Crohn's disease and cancer. N Engl J Med 1973; 289: 1099-1103.
3. Greenstein AJ, Sachar DB, Smith H, Janowitz HD, Aufses AH Jr: A comparison of cancer risk in Crohn's disease and ulcerative colitis. Cancer 1981; 48: 2742-2745. (Pubitemid 12194270)
4. Ekbom A, Helmick C, Zack M, Adami HO: Increased risk of large-bowel cancer in Crohn's disease with colonic involvement. Lancet 1990; 336: 357-359. (Pubitemid 20264156)
5. von Roon AC, Reese G, Teare J, Constantinides V, Darzi AW, Tekkis PP: The risk of cancer in patients with Crohn's disease. Dis Colon Rectum 2007; 50: 839-855. (Pubitemid 46870441)
6. Gillen CD, Andrews HA, Prior P, Allan RN: Crohn's disease and colorectal cancer. Gut 1994; 35: 651-655. (Pubitemid 24163792)
7. Jess T, Winther KV, Munkholm P, Langholz E, Binder V: Intestinal and extra-intestinal cancer in Crohn's disease: follow-up of a population-based cohort in Copenhagen county, Denmark. Aliment Pharmacol Ther 2004; 19: 287-293. (Pubitemid 38253503)
8. Yao T, Matsui T, Hiwatashi N: Crohn's disease in Japan: diagnostic criteria and epidemiology. Dis Colon Rectum 2000; 43:S85-S93.
9. Matsui T, Yao T, Sakurai T, Yao K, Hirai F, Matake H, Tsuda S, Wada Y, Iwashita A, Kamachi S: Clinical features and pattern of indeterminate colitis: Crohn's disease with ulcerative colitis-like clinical presentation. J Gastroenterol 2003; 38: 647-655. (Pubitemid 36974978)
10. Matsuda T, Marugame T, Kamo K, Katanoda K, Ajiki W, Sobue T: Cancer incidence and incidence rates in Japan in 2002: based on data from 11 population-based cancer registries. Jpn J Clin Oncol 2008; 38: 641-648.
11. Breslow NE DN: Methods in Cancer Research: The Design and Analysis of Cohort Studies. Lyon, IARC Scientific Publications, 1987.
12. Oriuchi T, Hiwatashi N, Kinouchi Y, Takahashi S, Takagi S, Negoro K, Shimosegawa T: Clinical course and long-term prognosis of Japanese patients with Crohn's disease: predictive factors, rates of operation, and mortality. J Gastroenterol 2003; 38: 942-953. (Pubitemid 37455781)
13. Katsanos KH, Christodoulou DK, Michael M, Ioachim E, Tsianos GV, Agnantis N, Tsianos EV: Inflammatory bowel disease-related dysplasia and cancer: a referral center study in northwestern Greece. Eur J Intern Med 2005; 16: 170-175. (Pubitemid 40828254)
14. Itzkowitz SH, Yio X: Inflammation and cancer. IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation. Am J Physiol Gastrointest Liver Physiol 2004; 287:G7-G17. (Pubitemid 38802113)
15. Canavan C, Abrams KR, Mayberry J: Metaanalysis: colorectal and small bowel cancer risk in patients with Crohn's disease. Aliment Pharmacol Ther 2006; 23: 1097-1104. (Pubitemid 43779348)
16. Higashi D, Futami K, Kawahara K, Kamitani T, Seki K, Naritomi K, Egawa Y, Hirano K, Tamura T, Tomiyasu T, Ishibashi Y, Simomura T, Nii K, Kinugasa T: Study of colorectal cancer with Crohn's disease. Anticancer Res 2007; 27: 3771-3774. (Pubitemid 47598443)
17. Ikeuchi H, Nakano H, Uchino M, Nakamura M, Matsuoka H, Fukuda Y, Matsumoto T, Takesue Y, Tomita N: Intestinal cancer in Crohn's disease. Hepatogastroenterology 2008; 55: 2121-2124.
18. Persson PG, Karlen P, Bernell O, Leijonmarck CE, Brostrom O, Ahlbom A, Hellers G: Crohn's disease and cancer: a populationbased cohort study. Gastroenterology 1994; 107: 1675-1679. (Pubitemid 24357620)
19. Gyde SN, Prior P, Macartney JC, Thompson H, Waterhouse JA, Allan RN: Malignancy in crohn's disease. Gut 1980; 21: 1024-1029. (Pubitemid 11184245)
20. Munkholm P, Langholz E, Davidsen M, Binder V: Intestinal cancer risk and mortality in patients with Crohn's disease. Gastroenterology 1993; 105: 1716-1723. (Pubitemid 24002788)
21. Kvist N, Jacobsen O, Norgaard P, Ockelmann HH, Kvist HK, Schou G, Jarnum S: Malignancy in Crohn's disease. Scand J Gastroenterol 1986; 21: 82-86. (Pubitemid 16177467)
22. Eaden JA, Mayberry JF: Guidelines for screening and surveillance of asymptomatic colorectal cancer in patients with inflammatory bowel disease. Gut 2002; 51(suppl 5):V10-V12.
23. Itzkowitz SH, Present DH: Consensus conference: colorectal cancer screening and surveillance in inflammatory bowel disease. Inflamm Bowel Dis 2005; 11: 314-321. (Pubitemid 40439686)
24. Friedman S, Rubin PH, Bodian C, Harpaz N, Present DH: Screening and surveillance colonoscopy in chronic Crohn's colitis: results of a surveillance program spanning 25 years. Clin Gastroenterol Hepatol 2008; 6: 993-998; quiz 953-994.
25. Mizushima T, Nezu R, Ito T, Uchikoshi F, Kai Y, Tamagawa H, Matsuda C, Yamagami Y, Inoue Y, Matsuda H: Three cases of colorectal cancer in patients with Crohn's disease. Nippon Shokakibyo Gakkai Zasshi 2005;102:912-917. (Pubitemid 41007739)
26. Gollop JH, Phillips SF, Melton LJ 3rd, Zinsmeister AR: Epidemiologic aspects of Crohn's disease: a population based study in Olmsted county, Minnesota, 1943-1982. Gut 1988; 29: 49-56.
27. Torres M, Matta E, Chinea B, Dueno MI, Martinez-Souss J, Ojeda A, Vega W, Toro DH: Malignant tumors of the small intestine. J Clin Gastroenterol 2003; 37: 372-380. (Pubitemid 37296165)
28. Ribeiro MB, Greenstein AJ, Sachar DB, Barth J, Balasubramanian S, Harpaz N, Heimann TM, Aufses AH Jr: Colorectal adenocarcinoma in Crohn's disease. Ann Surg 1996; 223: 186-193. (Pubitemid 26065212)
29. Kersting S, Bruewer M, Laukoetter MG, Rijcken EM, Mennigen R, Buerger H, Senninger N, Krieglstein CF: Intestinal cancer in patients with Crohn's disease. Int J Colorectal Dis 2007; 22: 411-417. (Pubitemid 46336245)
30. Ikeuchi H, Kusunoki M, Yamamura T, Nishigami T: Crohn's disease associated with gastric cancer. J Gastroenterol 2002; 37: 47-49. (Pubitemid 34144962)
31. Estlein D, Ohana G, Weil R, Rath-Wolfson L, Wolloch Y: Early cancer in gastric Crohn's disease. Isr Med Assoc J 2001; 3: 379-380. (Pubitemid 34176908)
32. Glick SN: Gastric carcinoma in patients with Crohn disease: report of four cases. AJR Am J Roentgenol 1991; 157: 311-314.
33. Inoue M, Tsugane S: Epidemiology of gastric cancer in Japan. Postgrad Med J 2005; 81: 419-424. (Pubitemid 41002579)
34. Greenstein AJ, Gennuso R, Sachar DB, Heimann T, Smith H, Janowitz HD, Aufses AH Jr: Extraintestinal cancers in inflammatory bowel disease. Cancer 1985; 56: 2914-2921. (Pubitemid 16216306)
35. Kane S, Khatibi B, Reddy D: Higher incidence of abnormal pap smears in women with inflammatory bowel disease. Am J Gastroenterol 2008; 103: 631-636. (Pubitemid 351405963)
36. Singh H, Demers AA, Nugent Z, Mahmud SM, Kliewer EV, Bernstein CN: Risk of cervical abnormalities in women with inflammatory bowel disease: a population-based nested case-control study. Gastroenterology 2009; 136: 451-458.
37. Greenstein AJ, Mullin GE, Strauchen JA, Heimann T, Janowitz HD, Aufses AH Jr, Sachar DB: Lymphoma in inflammatory bowel disease. Cancer 1992; 69: 1119-1123.
38. Bickston SJ, Lichtenstein GR, Arseneau KO, Cohen RB, Cominelli F: The relationship between infliximab treatment and lymphoma in Crohn's disease. Gastroenterology 1999; 117: 1433-1437.
39. Losco A, Gianelli U, Cassani B, Baldini L, Conte D, Basilisco G: Epstein-Barr virus-associated lymphoma in Crohn's disease. Inflamm Bowel Dis 2004; 10: 425-429. (Pubitemid 39029186)
40. Bouhnik Y, Lemann M, Mary JY, Scemama G, Tai R, Matuchansky C, Modigliani R, Rambaud JC: Long-term follow-up of patients with Crohn's disease treated with azathioprine or 6-mercaptopurine. Lancet 1996; 347: 215-219. (Pubitemid 26035245)
41. Farrell RJ, Ang Y, Kileen P, O'Briain DS, Kelleher D, Keeling PW, Weir DG: Increased incidence of non-Hodgkin's lymphoma in inflammatory bowel disease patients on immunosuppressive therapy but overall risk is low. Gut 2000; 47: 514-519.
42. Moss AC, Farrell RJ: Lymphoma risk with azathioprine/6-MP therapy - read beyond the headlines. Gastroenterology 2006; 130: 1363-1364.
43. Peyrin-Biroulet L, Deltenre P, de Suray N, Branche J, Sandborn WJ, Colombel JF: Efficacy and safety of tumor necrosis factor antagonists in Crohn's disease: meta-analysis of placebo-controlled trials. Clin Gastroenterol Hepatol 2008; 6: 644-653. (Pubitemid 351783447)